The Latest

  • MRI machine
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Bracco invests $230M to build US plant for injectable contrast media

    The Sanford, North Carolina, facility will become the company’s first manufacturing site for injectable contrast media in the U.S.

  • A person stands at a podium and speaks.
    Image attribution tooltip
    Permission granted by Resmed
    Image attribution tooltip
    Q&A

    AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry

    In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird’s eye view of the issues.

  • Image of healthcare equipment
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AI vendors, health systems join physicians in liability for clinical AI: AMA

    The AMA's new issue brief assigns distinct responsibilities to physicians, developers and healthcare organizations, arguing that protecting patients requires accountability from all stakeholders.

    AI
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts pivotal trial for mitral valve replacement device

    The study is testing a device that Abbott executives believe can expand the mitral valve market.

  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion

    Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.

  • An x-ray image of a person's pelvis shows a hip replacement on the left side.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Stryker lowers 2026 guidance after slowdown in hip, knee procedures

    CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also detailed the company’s decision to partner with CMR Surgical.

  • The facade of the U.S. Capitol building is seen along with trees and a reflection pond
    Image attribution tooltip
    Kara Arundel/MedTech Dive
    Image attribution tooltip

    Labcorp, Quest urge RESULTS Act passage as lab payment cuts loom

    The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross the finish line in Congress’ lame-duck session.

  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts alert about Medline beds linked to 2 deaths

    The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the market.

  • An image of an oval blue medical device.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

    The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

  • A person sits in a chair and gestures while speaking.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    3 highlights from EY’s report on 2026 medtech trends

    M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s Pulse of the Industry report.

    M&A
  • A building against a blue sky with trees and plants in front of it.
    Image attribution tooltip
    JHVEPhoto via Getty Images
    Image attribution tooltip

    Cooper Companies CEO steps down after activist investor pressure

    Weeks after an investor called for leadership changes, Cooper has parted ways with its CEO and proposed a new-look board of directors.

  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Boston Scientific cuts 2026 guidance for third time this year

    The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts once again.

  • A person looks at a computer screen with images of a person's brain.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    RadNet expands into teleradiology with $350M Onrad deal

    The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.

    M&A
  • The exterior of a convention center at sunrise is viewed from across the street.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Medical device leaders share AI hot takes at The MedTech Conference

    Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated industry.

    AI
  • A portrait of Rick Baehner
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott launches MRD test with improved cancer detection tech

    Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

  • The Stryker logo is displayed on an office building with hills in the background.
    Image attribution tooltip
    JHVEPhoto via Getty Images
    Image attribution tooltip

    Stryker completes ZuriMED takeover

    The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.

    M&A
  • A person sitting on a white couch speaks and looks to the side.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Overheard in Boston: Medtech CEOs talk rising costs, turbulent markets, cyberattacks

    At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, inflation and new technologies.

  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp inks Millennium Health buyout to add drug testing services

    The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.

    M&A
  • A person wearing goggles and a mask taps a tablet screen attached to a square machine.
    Image attribution tooltip
    Courtesy of Qiagen
    Image attribution tooltip

    Qiagen agrees to private equity takeover

    EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.

    M&A
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards wins FDA approval for tricuspid valve repair device

    Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.

  • An overhead shot of a conference hall shows many booths with people gathering.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    Medtech leaders discuss AI, cybersecurity and M&A at AdvaMed’s The MedTech Conference

    More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.

  • A sign for the Food And Drug Administration is seen
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Developers, not doctors, should be held accountable for generative AI medical devices, providers say

    Provider groups are lobbying the Food and Drug Administration to make tech companies responsible for the safety and performance of generative AI-backed medical devices, arguing the tools’ makers are best equipped to evaluate them.

    AI
  • An image of a horizontal building with a driveway.
    Image attribution tooltip
    Retrieved from Olympus on October 22, 2026
    Image attribution tooltip

    FDA flags more Olympus safety problems in import block and warning letter

    The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter identified numerous quality system violations.

    FDA
  • A picture of San Francisco's Coit Tower and downtown at dawn.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Top medtech conferences in 2027

    From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.

  • Quest Diagnostics building
    Image attribution tooltip
    Courtesy of Quest Diagnostics
    Image attribution tooltip

    Quest Diagnostics hit by cyberattack

    The testing company believes an unauthorized third party accessed patient records.